Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0880520180540030167
Chonnam Medical Journal
2018 Volume.54 No. 3 p.167 ~ p.172
Effects of Ivabradine on Left Ventricular Systolic Function and Cardiac Fibrosis in Rat Myocardial Ischemia-Reperfusion Model
Kim Han-Byul

Hong Young-Joon
Park Hyuk-Jin
Ahn Young-Keun
Jeong Myung-Ho
Abstract
We evaluated the effects of Ivabradine on left ventricle (LV) ejection fraction (EF) and LV infarcted tissue in the rat myocardial ischemia-reperfusion model. Twenty rats were randomly assigned to group 1 (ischemia-reperfusion, no treatment, n=10) and group 2 (ischemia-reperfusion + Ivabradine 10 mg/kg, n=10). Ivabradine was administered for 28 days. Echocardiography was performed at 7 days and at 28 days after the induction of ischemia-reperfusion injury. Cardiac fibrosis induced by ischemia-reperfusion injury was evaluated by Masson's trichrome staining. The infarct size was quantified using the Image J program. At the 28-day follow-up, LVEF was significantly higher (36.02¡¾6.16% vs. 45.72¡¾2.62%, p<0.001) and fractional shortening was significantly higher (15.23¡¾2.84% vs. 20.13¡¾1.38%, p<0.001) in group 2 than group 1. Delta (28 day minus 7 day) EF was significantly higher in group 2 than group 1 (?4.36¡¾3.49% vs. 4.31¡¾5.63%, p<0.001). Also, heart rate (beats/min) was significantly lower in group 2 than group 1 (251.67¡¾25.19 vs. 199.29¡¾31.33, p=0.025). Group 2 had a smaller infarct size (40.70¡¾8.94% vs. 30.19¡¾5.89%, p<0.01) than group 1 at 28-day follow-up. Oral administration of Ivabradine could improve LV systolic function and reduce infarcted tissue area in rat myocardial ischemia-reperfusion model.
KEYWORD
Myocardial Ischemia, Myocardial Reperfusion Injury, Echocardiography, Ivabradine
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed